Extracellular matrix-resident growth factors and enzymes: possible involvement in tumor metastasis and angiogenesis

CANCER AND METASTASIS REVIEW

Volumn 9, Issue 3, 1990, Pages 203-226

  Vlodavsky, Israel ^a   Korner, Gil ^a   Ishai Michaeli, Rivka ^a   Bashkin, Pnina ^a   Bar Shavit, Rachel ^a   Fuks, Zvi ^b  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

angiogenesis; basic fibroblast growth factor; endothelial cells; extracellular matrix; heparanase; metastasis

Indexed keywords

FIBROBLAST GROWTH FACTOR; HEPARANASE;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; EXTRACELLULAR MATRIX; HISTOCHEMISTRY; HISTOLOGY; HUMAN; HUMAN CELL; METASTASIS; NONHUMAN; PRIORITY JOURNAL; REVIEW; TUMOR GROWTH;

ANIMAL; EXTRACELLULAR MATRIX; FIBROBLAST GROWTH FACTOR 2; GLYCOSIDE HYDROLASES; HEPARITIN SULFATE; HUMAN; NEOPLASM METASTASIS; NEOVASCULARIZATION, PATHOLOGIC; PLASMINOGEN ACTIVATORS; PLASMINOGEN INACTIVATORS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, NON-P.H.S.; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0025013701     PISSN: 01677659     EISSN: 15737233     Source Type: Journal    
DOI: 10.1007/BF00046361     Document Type: Article

References (113)

1. Mechanism of organogenetic tissue interaction
2. Extracellular matrix
3. Collagenous bone matrix induced endochondral ossification and hemopoiesis
4. Dependence of salivary epithelial morphology and branching morphogenesis upon acid mucopolysaccharide protein of the epithelial surface
5. On the nature of tissue interactions in embryonic skin
6. Substrate and nutrient effects upon epidermal basal cell differentiation and proliferation
7. Development of the vertebrate cornea
8. Increased content of type V collagen in desmoplasia of human breast carcinoma
9. Growth factors and extracellular matrix
10. Role of collagenous matrices in the adhesion and growth of cells
11. Lumen formation by epithelial cell lines in response to collagen overlay: a morphogenetic model in culture
12. Hepatocyte proliferation in vitro: its dependence on the use of serum free, hormonally defined medium and substrate of extracellular matrix
13. Permissive effect of the extracellular matrix on cell proliferation in vitro
14. Morphological appearance, growth behavior and migratory activity of human tumor cells maintained on extracellular matrix vs plastic
15. The extracellular matrix and the control of proliferation of vascular endothelial and vascular smooth muscle cells
16. Induction of cell attachment and morphological differentiation in a pheochromocytoma cell line and embryonal sensory cells by the extracellular matrix
17. Loss of basement membrane components by invasive tumors but not by their benign counterparts
18. Comparison of the ability of basement membranes produced by corneal endothelial and mouse-derived endodermal PF-HR-9 cells to support the proliferation and differentiation of bovine kidney tubule epithelial cells in vitro
19. Are factors originating from serum, plasma or cultured cells involved in the growth promoting effect of the extracellular matrix produced by cultured bovine corneal endothelial cells
20. Do plasma and serum have different abilities to promote cell growth?
21. High density lipoprotein and the growth of vascular endothelial cells in serum free medium
22. Cell interaction with the extracellular matrices produced by endothelial cells and fibroblasts
23. Arg-Gly-Asp: A versatile cell recognition signal
24. Integrins: A family of cell surface receptors
25. Neovascularization in human cutaneous melanoma: A quantitative morphological and doppler ultra sound study
26. Angiogenic factors
27. The heparin-binding (fibroblast) growth factor family of proteins
28. Structural characterization and biological functions of fibroblast growth factor
29. Clinical applications of heparin-binding growth factors
30. Transforming potential of fibroblast growth factor genes
31. Recent developments in the cell biology of basic fibroblast growth factor
32. Purification of a factor from human placenta that stimulates capillary endothelial cell protease production, DNA synthesis, and migration
33. Endothelial cell-derived basic fibroblast growth factor: Synthesis and deposition into subendothelial extracellular matrix
34. Fibroblast growth factors are present in the extracellular matrix produced by endothelial cells in vitro: Implications for a role of heparinase-like enzymes in the neovascular response
35. Acidic fibroblast growth factor mRNA is expressed by cardiac myocytes in culture and the protein is localized to the extracellular matrix
36. Heparin protects basic and acidic FGF from inactivation
37. Fibroblast growth factors
38. Aortic endothelial cells synthesize basic fibroblast growth factor which remains cell associated and platelet-derived growth factor which is secreted
39. Nucleotide sequence of a bovine clone encoding the angiogenic protein basic fibroblast growth factor
40. Differential structural requirements for the induction of cell attachment, proliferation and differentiation by the extracellular matrix
41. Human endothelial cells: use of heparin in cloning and long-term serial cultivation
42. Characterization of glycosaminoglycans synthesized by the cultured bovine corneal endothelial cells
43. Capillary endothelial cells express basic fibroblast growth factor, a mitogen that promotes their own growth
44. Both normal and tumor cells produce basic fibroblast growth factor
45. A heparin-binding angiogenic protein-basic fibroblast growth factor-is stored within basement membrane
46. Localization of basic fibroblast growth factor to the developing capillaries of bovine retina
47. Basic fibroblast growth factor in the chick embryo: immunolocalization to striated muscle cells and their precursors
48. Basic fibroblast growth factor in atria and ventricles of the vertebrate heart
49. Neutralizing antibodies inhibit the binding of basic fibroblast growth factor to its receptor but not to heparin
50. Basic fibroblast growth factor is an extracellular matrix component required for supporting the proliferation of vascular endothelial cells and the differentiation of PC12 cells
51. Basic fibroblast growth factor fused to a signal peptide transforms cells
52. Differential effects of heparin, fibronectin and laminin on the phosphorylation of basic fibroblast growth factor by protein kinase C and the catalytic subunit of protein kinase A
53. Basic fibroblast growth factor binds to subendothelial extracellular matrix and is released by heparanase and heparin-like molecules
54. High and low affinity binding sites for basic fibroblast growth factor on cultured cells: absence of a role for low affinity binding in the stimulation of plasminogen activator production by bovine capillary endothelial cells
55. Basic fibroblast growth factor is released from endothelial extracellular matrix in a biologically active form
56. Lymphoma cell mediated degradation of sulfated proteoglycans in the subendothelial extracellular matrix: Relationship to tumor cell metastasis
57. Heparanases and tumor metastasis
58. Degradation of sulfated proteoglycans in the subendothelial extracellular matrix by human platelet heparitinase
59. Degradation of heparan sulfate in the subendothelial basement membrane by a readily released heparanase from human neutrophils
60. Interaction of T lymphocytes and macrophages with cultured vascular endothelial cells: Attachment, invasion and subsequent degradation of the subendothelial extracellular matrix
61. Activated T lymphocytes produce a matrix-degrading heparan sulfate endoglycosidase
62. Immunoreactive fibroblast growth factor in cells of peritoneal exudate suggests its identity with macrophage derived growth factor
63. Identification of angiogenic activity and the cloning and expression of platelet-derived endothelial cell growth factor
64. Degranulating mast cells secrete an endoglycosidase that degrades heparan sulfate in subendothelial extracellular matrix
65. Mast cell and tumor angiogenesis
66. Role of extracellular matrix in the action of bFGF: Matrix as a source of growth factor for long-term stimulation of plasminogen activator and DNA synthesis
67. Involvement of phosphatidylinositol and insulin in the coordinate regulation of proteoheparan sulfate metabolism and hepatocyte growth
68. Effects of irradiation on the release of growth factors from cultured bovine, porcine, and human endothelial cells
69. Tumor invasion and the extracellular matrix
70. Extracellular matrix destruction by invasive tumor cells
71. Cell surface heparan sulfate mediates some adhesive responses to glycosami-noglycan-binding matrices, including fibronectin
72. Involvement of heparanase in tumor metastasis and angiogenesis
73. Evidence that sulphated polysaccharides inhibit tumor metastasis by blocking tumor cell-derived heparanase
74. Plasminogen activators, tissue degradation and cancer
75. Laminin interacts with plasminogen and its tissue-type activator
76. Limited cleavage of cellular fibronectin by plasminogen activator purified from transformed cells
77. Growth factors in the regulation of pericellular proteolysis: A review
78. An anticatalytic monoclonal antibody to avian plasminogen activator: its effect on behavior of RSV-transformed chick fibroblasts
79. Involvement of both heparanase and plasminogen activator in lymphoma cell mediated degradation of heparan sulfate in the subendothelial extracellular matrix
80. The interaction of plasminogen activator with a reconstituted basement membrane matrix and extracellular macromolecules produced by cultured epithelial cells
81. Fibronectin degrading proteases from the membranes of transformed Cells
82. Distinct localization of urokinase-type plasminogen activator and its type 1 inhibitor under cultured human fibroblasts and sarcoma cells
83. Effect of plasminogen activator (urokinase), plasmin and thrombin on glycoprotein and collagenous components of basement membrane
84. Immunocytochemical localization of urokinase-type plasminogen activator in Lewis lung carcinoma
85. Antibodies to plasminogen activator inhibit human tumor metastasis
86. Plasminogen activator dependent pathway in the dissemination of human tumor cells in the chick embryo
87. Extracellular matrix of cultured bovine aortic endothelial cells contains functionally active type 1 plasminogen activator inhibitor
88. Plasminogen activator inhibitor is associated with the extracellular matrix of cultured bovine smooth muscle cells
89. Fibrinolytic system of vascular endothelial cells: Role of plasminogen activator inhibitors
90. Interaction of plasminogen activator inhibitor (PAI-1) with vitronectin
91. The opposing effects of basic fibroblast growth factor and transforming growth factor-on regulation of plasminogen activator activity in capillary endothelial cells
92. Mechanochemical switching between growth and differentiation during fibroblast growth factor-stimulated angiogenesis in vitro: role of extracellular matrix
93. Compart-mentalization of a haematopoietic growth factor (GM, CSF) by glycosaminoglycans in the bone marrow microen-vironment
94. Heparan sulphate bound growth factors: a mechanism for stromal cell mediated haemopoiesis
95. Transforming growth factor-β (TGFβ) receptor proteoglycan. Cell surface expression and ligand binding in the absence of glycosaminoglycan chains
96. Membrane-anchored and soluble forms of betaglycan, a polymorphic proteoglycan that binds transforming growth factor-β
97. Some recent advances in the chemistry and biology of transforming growth factor-β
98. Isolation of osteogenin, an extracellular matrix associated bone inductive protein, by heparin affinity chromatography
99. Growth factors in bone matrix. Isolation and multiple types by affinity chromatography on heparin-Sepharose
100. Domains of laminin with growth-factor activity
101. Binding of thrombin to subendothelial extracellular matrix: protection and expression of functional properties
102. Binding of plasminogen to extracellular matrix
103. Interaction of lipoprotein lipase with subendothelial extracellular matrix
104. The distribution of secondary growth of cancer of the breast
105. Influence of organ environment on the growth, selection and metastasis of human colon carcinoma cells in nude mice
106. Purification and some properties of lung-derived growth factor that differentially stimulates the growth of tumor cells metastatic to the lung
107. Transformation of murine melanocytes by bFGF cDNA and oncogens and selective suppression of the transformed phenotype in a reconstituted cutaneous environment